You Yahong, Huo Jiali, Huang Jinbo, Wang Min, Shao Yingqi, Ge Meili, Li Xingxin, Huang Zhendong, Zhang Jing, Nie Neng, Zheng Yizhou
State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, P. R. China.
J Cell Biochem. 2019 Jul;120(7):11409-11417. doi: 10.1002/jcb.28418. Epub 2019 Feb 14.
Immune-mediated quantitative and qualitative defects of hematopoietic stem/progenitor cells (HSPCs) play a vital role in the pathophysiology of acquired aplastic anemia (AA). Autophagy is closely related to T cell pathophysiology and the destiny of HSPCs, in which autophagy-related gene 5 (ATG5) is indispensably involved. We hypothesized that genetic variants of ATG5 might contribute to AA. We studied six ATG5 polymorphisms in a Chinese cohort of 176 patients with AA to compare with 157 healthy controls. A markedly decreased risk of AA in the recessive models of rs510432 and rs803360 polymorphisms (adjusted odds ratio [OR], 95% confidence interval [CI] = 0.467 [0.236-0.924], P = 0.029 for ATG5 rs510432; adjusted OR [95% CI] = 0.499 [0.255-0.975], P = 0.042 for ATG5 rs803360) was observed. Furthermore, the decreased risk was even more pronounced among nonsevere AA compared with healthy controls under recessive models (adjusted OR [95% CI] = 0.356 [0.141-0.901], P = 0.029 for ATG5 rs510432; adjusted OR [95% CI] = 0.348 [0.138-0.878], P = 0.025 for ATG5 rs803360; adjusted OR [95% CI] = 0.352 [0.139-0.891], P = 0.027 for ATG5 rs473543). Above all, rs573775 can strongly predict the occurrence of newly onset hematological event in patients with AA. Our results indicate that genetic ATG5 variants contributed to AA, which may facilitate further clarifying the underlying mechanisms of AA and making a patient-tailored medical decision.
免疫介导的造血干/祖细胞(HSPCs)数量和质量缺陷在获得性再生障碍性贫血(AA)的病理生理过程中起关键作用。自噬与T细胞病理生理及HSPCs的命运密切相关,其中自噬相关基因5(ATG5)不可或缺。我们推测ATG5基因变异可能与AA有关。我们在中国的176例AA患者队列中研究了6种ATG5多态性,并与157名健康对照进行比较。在rs510432和rs803360多态性的隐性模型中,AA风险显著降低(校正比值比[OR],95%置信区间[CI] = 0.467 [0.236 - 0.924],ATG5 rs510432的P = 0.029;校正OR [95% CI] = 0.499 [0.255 - 0.975],ATG5 rs803360的P = 0.042)。此外,在隐性模型下,与健康对照相比,非重型AA患者的风险降低更为明显(ATG5 rs510432的校正OR [95% CI] = 0.356 [0.141 - 0.901],P = 0.029;ATG5 rs803360的校正OR [95% CI] = 0.348 [0.138 - 0.878],P = 0.025;ATG5 rs473543的校正OR [95% CI] = 0.352 [0.139 - 0.891],P = 0.027)。最重要的是,rs573775可强烈预测AA患者新发血液学事件的发生。我们的结果表明ATG5基因变异与AA有关,这可能有助于进一步阐明AA的潜在机制并做出针对患者的医疗决策。